ZK International Announces Record Revenue of $54.9 million, a 22.1% Increase Year-Over-Year, for the Fiscal Year 2018

Gross profit increases 39.5% year-over-year to $18.3 million driven by an increase in gross profit margins to 33.3% WENZHOU, China, Feb. 4, 2019 /PRNewswire/ — ZK International Group Co., Ltd. (NASDAQ: ZKIN) (“ZKIN”, “ZK International” or the “Company”), a designer, engineer, manufacturer, and supplier of patented high-performance stainless steel and carbon steel pipe products that require sophisticated water or gas pipeline systems, today announced … Continue reading “ZK International Announces Record Revenue of $54.9 million, a 22.1% Increase Year-Over-Year, for the Fiscal Year 2018”

FABU Technology Selects Synopsys’ DesignWare IP Portfolio to Deliver Intelligence in ADAS and Autonomous Driving SoCs

MOUNTAIN VIEW, Calif., and TEMPE, Ariz., Feb. 4, 2019 /PRNewswire/ — Synopsys, Inc. (Nasdaq:  SNPS) and FABU Technology Co., Ltd. today announced that FABU has selected a portfolio of silicon-proven Synopsys DesignWare®Interface, Security, ARC® EM Safety Island Processor, and Embedded Memory Test and Repair IP to deliver high-performance artificial intelligence (AI) system-on-chips (SoCs) for advanced automotive applications. FABU develops intelligent chips for … Continue reading “FABU Technology Selects Synopsys’ DesignWare IP Portfolio to Deliver Intelligence in ADAS and Autonomous Driving SoCs”

Palo Alto Networks Fuels Channel Growth With NextWave Partner Program Enhancements

SANTA CLARA, Calif., Feb. 4, 2019 /PRNewswire/ — Palo Alto Networks (NYSE:  PANW), the global cybersecurity leader, today announced several enhancements to its NextWave Partner Program, which will boost program flexibility, fuel long-term growth and enable the expansion of partner-led services. NextWave enhancements include: New profitability initiatives: Palo Alto Networks introduced new options for partners to grow their businesses with streamlined … Continue reading “Palo Alto Networks Fuels Channel Growth With NextWave Partner Program Enhancements”

Delta Reports Operating Performance for January 2019

ATLANTA, Feb. 4, 2019 /PRNewswire/ — Delta Air Lines (NYSE: DAL) today reported operating performance for January 2019. The company carried 14.1 million customers across its broad global network. Monthly highlights include: Announcing the extension of the Airbus A220 order book by 15 additional aircraft for a total of 90 aircraft and converting 35 existing A220-100 orders into the … Continue reading “Delta Reports Operating Performance for January 2019”

Valvoline Launches Legends of Racing Bobblehead Retail Promotion

LEXINGTON, Ky., Jan. 31, 2019 /PRNewswire/ — Valvoline Inc. (NYSE: VVV), a leading worldwide supplier of premium branded lubricants and automotive services, today announced the launch of a custom-designed Legends of Racing Bobblehead national retail promotion. Now through May 1, 2019, with every 5 quarts of any Valvoline motor oil purchased at select retailers, customers will have the opportunity to receive … Continue reading “Valvoline Launches Legends of Racing Bobblehead Retail Promotion”

BJ Services Fuels Operational Excellence with Coupa

SAN MATEO, Calif., Jan. 31, 2019 /PRNewswire/ — Coupa Software (NASDAQ: COUP), a leader in business spend management (BSM), today announced that BJ Services, a leading provider of pressure pumping services for the oil and gas industry, has selected Coupa to transform its business by automating its accounts payable (AP) and eInvoicing processes. Located in Tomball, Texas near Houston, BJ Services is the largest … Continue reading “BJ Services Fuels Operational Excellence with Coupa”

Gold Coast Health Plan Selects Conduent for Medicaid Managed Care Administration

FLORHAM PARK, N.J., Jan. 31, 2019 /PRNewswire/ — Conduent Incorporated (NYSE: CNDT), a digital interactions company, was awarded a $100 million, seven-year contract extension to provide third-party administration services for Gold Coast Health Plan (GCHP), a Ventura County, Calif.-based Medi-Cal plan. Conduent will deploy an end-to-end plan administration platform, including member experience and automation tools, for GCHP, which manages the Medi-Cal benefit for nearly … Continue reading “Gold Coast Health Plan Selects Conduent for Medicaid Managed Care Administration”

ISG Launches Global Study on Private and Hybrid Cloud Data Center Services

STAMFORD, Conn., Jan. 31, 2019 /PRNewswire/ — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining the global market for private and hybrid cloud data center services and solutions. Results will be published in a comprehensive ISG Provider Lens™ report, “Private/Hybrid Cloud – Data Center Services & Solutions … Continue reading “ISG Launches Global Study on Private and Hybrid Cloud Data Center Services”

Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.’s Apomorphine Sublingual Film (APL-130277) New Drug Application

WARREN, N.J., Jan. 31, 2019 /PRNewswire/ — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, learned today its licensee, Sunovion Pharmaceuticals Inc., received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for apomorphine … Continue reading “Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.’s Apomorphine Sublingual Film (APL-130277) New Drug Application”

Trovagene and PoC Capital Enter Agreement to Fund Clinical Development of Onvansertib in Metastatic Colorectal Cancer (mCRC)

SAN DIEGO, Jan. 29, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq:  TROV), a clinical-stage oncology therapeutics company, developing drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced an agreement with PoC Capital, LLC, to fund clinical development of Onvansertib, Trovagene’s first-in-class, 3rd generation oral and highly selective Polo-like Kinase 1 (PLK1) inhibitor … Continue reading “Trovagene and PoC Capital Enter Agreement to Fund Clinical Development of Onvansertib in Metastatic Colorectal Cancer (mCRC)”